187 related articles for article (PubMed ID: 23110854)
1. Implantable cardioverter defibrillator shocks are prospective predictors of anxiety.
Schulz SM; Massa C; Grzbiela A; Dengler W; Wiedemann G; Pauli P
Heart Lung; 2013; 42(2):105-11. PubMed ID: 23110854
[TBL] [Abstract][Full Text] [Related]
2. Stability and cause of anxiety in patients with an implantable cardioverter-defibrillator: a longitudinal two-year follow-up.
Crössmann A; Pauli P; Dengler W; Kühlkamp V; Wiedemann G
Heart Lung; 2007; 36(2):87-95. PubMed ID: 17362789
[TBL] [Abstract][Full Text] [Related]
3. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks.
Pedersen SS; van Domburg RT; Theuns DA; Jordaens L; Erdman RA
Am Heart J; 2005 Apr; 149(4):664-9. PubMed ID: 15990750
[TBL] [Abstract][Full Text] [Related]
4. Comorbidity burden is associated with poor psychological well-being and physical health status in patients with an implantable cardioverter-defibrillator.
Hoogwegt MT; Kupper N; Jordaens L; Pedersen SS; Theuns DA
Europace; 2013 Oct; 15(10):1468-74. PubMed ID: 23608028
[TBL] [Abstract][Full Text] [Related]
5. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
[TBL] [Abstract][Full Text] [Related]
6. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
[TBL] [Abstract][Full Text] [Related]
7. Resource loss predicts depression and anxiety among patients treated with an implantable cardioverter defibrillator.
Luyster FS; Hughes JW; Waechter D; Josephson R
Psychosom Med; 2006; 68(5):794-800. PubMed ID: 17012535
[TBL] [Abstract][Full Text] [Related]
8. Poor health status and distress in cardiac patients: the role of device therapy vs. underlying heart disease.
Habibović M; Versteeg H; Pelle AJ; Theuns DA; Jordaens L; Pedersen SS
Europace; 2013 Mar; 15(3):355-61. PubMed ID: 22989939
[TBL] [Abstract][Full Text] [Related]
9. Shocks, personality, and anxiety in patients with an implantable defibrillator.
Van den Broek KC; Nyklícek I; Van der Voort PH; Alings M; Denollet J
Pacing Clin Electrophysiol; 2008 Jul; 31(7):850-7. PubMed ID: 18684282
[TBL] [Abstract][Full Text] [Related]
10. Monitoring treatment expectations in patients with an implantable cardioverter-defibrillator using the EXPECT-ICD scale.
Habibović M; Pedersen SS; van den Broek KC; Denollet J
Europace; 2014 Jul; 16(7):1022-7. PubMed ID: 24596397
[TBL] [Abstract][Full Text] [Related]
11. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors.
Bilge AK; Ozben B; Demircan S; Cinar M; Yilmaz E; Adalet K
Pacing Clin Electrophysiol; 2006 Jun; 29(6):619-26. PubMed ID: 16784428
[TBL] [Abstract][Full Text] [Related]
12. Psychological indices as predictors for phantom shocks in implantable cardioverter defibrillator recipients.
Starrenburg A; Kraaier K; Pedersen S; Scholten M; Van Der Palen J
Pacing Clin Electrophysiol; 2014 Jun; 37(6):768-73. PubMed ID: 24456312
[TBL] [Abstract][Full Text] [Related]
13. Phantom shocks in patients with implantable cardioverter defibrillator: results from a randomized rehabilitation trial (COPE-ICD).
Berg SK; Moons P; Zwisler AD; Winkel P; Pedersen BD; Pedersen PU; Svendsen JH
Europace; 2013 Oct; 15(10):1463-7. PubMed ID: 23599170
[TBL] [Abstract][Full Text] [Related]
14. Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study.
Albert CM; Rosenthal L; Calkins H; Steinberg JS; Ruskin JN; Wang P; Muller JE; Mittleman MA;
J Am Coll Cardiol; 2007 Dec; 50(23):2233-40. PubMed ID: 18061071
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
Kron J; Sauer W; Schuller J; Bogun F; Crawford T; Sarsam S; Rosenfeld L; Mitiku TY; Cooper JM; Mehta D; Greenspon AJ; Ortman M; Delurgio DB; Valadri R; Narasimhan C; Swapna N; Singh JP; Danik S; Markowitz SM; Almquist AK; Krahn AD; Wolfe LG; Feinstein S; Ellenbogen KA
Europace; 2013 Mar; 15(3):347-54. PubMed ID: 23002195
[TBL] [Abstract][Full Text] [Related]
16. Concerns about implantable cardioverter-defibrillator shocks mediate the relationship between actual shocks and psychological distress.
Thylén I; Moser DK; Strömberg A; Dekker RA; Chung ML
Europace; 2016 Jun; 18(6):828-35. PubMed ID: 26324839
[TBL] [Abstract][Full Text] [Related]
17. Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy.
Perini AP; Kutyifa V; Veazie P; Daubert JP; Schuger C; Zareba W; McNitt S; Rosero S; Tompkins C; Padeletti L; Moss AJ
Am Heart J; 2017 Jul; 189():75-84. PubMed ID: 28625384
[TBL] [Abstract][Full Text] [Related]
18. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators.
Kolb C; Deisenhofer I; Schmieder S; Barthel P; Zrenner B; Karch MR; Schmitt C
Pacing Clin Electrophysiol; 2006 Sep; 29(9):946-52. PubMed ID: 16981917
[TBL] [Abstract][Full Text] [Related]
20. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study.
Whang W; Albert CM; Sears SF; Lampert R; Conti JB; Wang PJ; Singh JP; Ruskin JN; Muller JE; Mittleman MA;
J Am Coll Cardiol; 2005 Apr; 45(7):1090-5. PubMed ID: 15808769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
